Company / Cash per Share
Mereo BioPharma Group plc Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.06
FY2025
5-year range
$0.06 / $0.11
FY2023-FY2025
Trend
-47.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.10 to $0.06 over the past 2 years.
Based on SEC 10-K filings.
0.06 in FY2025.
Declined from $0.10 to $0.06 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share decreased 47.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | -47.6% |
| FY2024 | $0.11 | +11.2% |
| FY2023 | $0.10 | - |
As of FY2025 · SEC 10-K · Updated Jun 27, 2026